Exact Sciences (NASDAQ: EXAS)
Exact Sciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Exact Sciences Company Info
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
News & Analysis
Investing in Genetic Testing Stocks
Investing in Genomics Stocks
Can This Beaten-Down Cathie Wood Stock Bounce Back?
An updated version of Exact Sciences' key product just got regulatory approval. That could help the healthcare stock stage a comeback.
This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street
Investors shouldn't rush to buy the stock based on rosy short-term price targets.
1 Beaten-Down Cathie Wood Stock to Buy and Hold
This company is innovating where it matters most, which could prove highly lucrative down the road.
2 Beaten-Down Cathie Wood Stocks With Massive Potential
They won't lag the market forever.
Cathie Wood Is Selling This Stock: Should You?
This company hasn't performed well in the past 12 months.
2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul
These stocks can reward patient investors.
Valuation
Earnings Transcripts
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript
EXAS earnings call for the period ending December 31, 2024.
Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2024.
Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript
EXAS earnings call for the period ending June 30, 2024.
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
EXAS earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.